William E. Janssen

5.2k total citations · 1 hit paper
84 papers, 3.7k citations indexed

About

William E. Janssen is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, William E. Janssen has authored 84 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 31 papers in Oncology and 26 papers in Immunology. Recurrent topics in William E. Janssen's work include Hematopoietic Stem Cell Transplantation (31 papers), Immunotherapy and Immune Responses (16 papers) and CAR-T cell therapy research (11 papers). William E. Janssen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (31 papers), Immunotherapy and Immune Responses (16 papers) and CAR-T cell therapy research (11 papers). William E. Janssen collaborates with scholars based in United States, Germany and Spain. William E. Janssen's co-authors include Juan Sanchez‐Ramos, Thomas B. Freeman, Todd Stedeford, Paul R. Sanberg, Samuel Saporta, Shijie Song, Denise R. Cooper, Niketa Patel, Alison E. Willing and Fernando Cardozo‐Pelaez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

William E. Janssen

82 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro

2000 1.3k citations William E. Janssen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
William E. Janssen	1.3k	1.2k	1.1k	1.0k	759	84	3.7k
Akiko Shimamura	778 0.6×	625 0.5×	4.0k 3.7×	1.2k 1.2×	1.5k 1.9×	128	6.6k
Christian Sirard	2.7k 2.0×	593 0.5×	3.7k 3.5×	784 0.8×	1.2k 1.5×	16	6.1k
Michael J. Reitsma	816 0.6×	1.6k 1.3×	2.3k 2.1×	324 0.3×	489 0.6×	15	4.4k
Volker Eckstein	1.3k 1.0×	2.9k 2.5×	2.2k 2.0×	1.2k 1.2×	1.4k 1.8×	121	6.4k
Ryan Reca	1.5k 1.2×	1.4k 1.2×	3.3k 3.0×	1.6k 1.5×	953 1.3×	43	6.0k
Sheri Miraglia	1.4k 1.1×	522 0.4×	1.5k 1.4×	434 0.4×	404 0.5×	12	3.0k
Anna Corcione	688 0.5×	1.3k 1.2×	620 0.6×	1.2k 1.2×	457 0.6×	56	3.0k
Marina Podestà	679 0.5×	1.7k 1.5×	830 0.8×	970 0.9×	2.0k 2.6×	138	4.0k
James Dalton	797 0.6×	1.9k 1.6×	2.3k 2.2×	213 0.2×	733 1.0×	44	5.2k
Alexander Medvinsky	523 0.4×	582 0.5×	3.7k 3.4×	1.8k 1.8×	1.9k 2.5×	66	6.6k

Countries citing papers authored by William E. Janssen

Since Specialization

Citations

This map shows the geographic impact of William E. Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Janssen more than expected).

Fields of papers citing papers by William E. Janssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Janssen. The network helps show where William E. Janssen may publish in the future.

Co-authorship network of co-authors of William E. Janssen

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Janssen. A scholar is included among the top collaborators of William E. Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Janssen. William E. Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Federico, Sara M., M. Beth McCarville, Barry L. Shulkin, et al.. (2017). A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma. Clinical Cancer Research. 23(21). 6441–6449. 114 indexed citations

Eldridge, Paul, Deborah Griffin, William E. Janssen, & Lynn O’Donnell. (2015). Part 3: Understanding the manufacturing of unproven cellular therapy products. Cytotherapy. 18(1). 124–126. 2 indexed citations

Janssen, William E., et al.. (2015). Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworks. Cytotherapy. 18(1). 127–137. 6 indexed citations

Janssen, William E., et al.. (2012). Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 years. Bone Marrow Transplantation. 47(12). 1520–1525. 4 indexed citations

Pilon‐Thomas, Shari, Lisa Kühn, William E. Janssen, et al.. (2012). Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma. Journal of Immunotherapy. 35(8). 615–620. 143 indexed citations

Finkelstein, Steven E., Cristina Iclozan, Marilyn M. Bui, et al.. (2011). Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients. International Journal of Radiation Oncology*Biology*Physics. 82(2). 924–932. 101 indexed citations

Kharfan‐Dabaja, Mohamed A., Julio C. Chávez, Daohai Yu, et al.. (2010). Severe Hypoalbuminemia at Day 90 Predicts Worse Nonrelapse Mortality and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 17(3). 384–393. 23 indexed citations

Chiappori, Alberto, Hatem Soliman, William E. Janssen, Scott Antonia, & Dmitry I. Gabrilovich. (2010). INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect. Expert Opinion on Biological Therapy. 10(6). 983–991. 98 indexed citations

Hoda, Daanish, Joseph Pidala, Janelle Perkins, et al.. (2009). Sirolimus for treatment of steroid-refractory acute graft-versus-host disease. Bone Marrow Transplantation. 45(8). 1347–1351. 54 indexed citations

10.

Janssen, William E.. (2008). Data management in the cell therapy production facility: the batch process record (BPR). Cytotherapy. 10(3). 227–237. 3 indexed citations

11.

Fishman, Mayer, Terri Hunter, Hatem Soliman, et al.. (2008). Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma. Journal of Immunotherapy. 31(1). 72–80. 52 indexed citations

12.

Dessureault, Sophie, David Noyes, David Lee, et al.. (2006). A phase-I Trial Using a Universal GM-CSF-producing and CD40L-expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-based Vaccines for Cancer Patients with Stage IV disease. Annals of Surgical Oncology. 14(2). 869–884. 35 indexed citations

13.

Tummala, Raj, William E. Janssen, J. Hiemenz, et al.. (1997). High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency. Bone Marrow Transplantation. 20(8). 653–656. 58 indexed citations

14.

Sackstein, Robert, William E. Janssen, & Gerald J. Elfenbein. (1995). Bone marrow transplantation : foundations for the 21st century. New York Academy of Sciences eBooks. 8 indexed citations

15.

Elfenbein, Gerald J., William E. Janssen, & Janelle Perkins. (1995). Relative Contributions of Marrow Microenvironment, Growth Factors, and Stem Cells to Hematopoiesis in Vivo in Man. Annals of the New York Academy of Sciences. 770(1). 315–338. 6 indexed citations

16.

Janssen, William E.. (1995). Mobilization of Peripheral Blood Stem Cells for Autologous Transplantation. Annals of the New York Academy of Sciences. 770(1). 116–129. 3 indexed citations

17.

Janssen, William E., et al.. (1992). Use of the Terumo SteriCell for the Processing of Bone Marrow and Peripheral Blood Stem Cells. Journal of Hematotherapy. 1(4). 349–359. 4 indexed citations

18.

Casper, J., Gerald J. Elfenbein, A Gee, et al.. (1991). High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study.. Journal of Clinical Oncology. 9(1). 152–158. 88 indexed citations

19.

Gee, A, et al.. (1990). Immunomagnetic Purging of Bone Marrow. Journal of Pediatric Hematology/Oncology. 12(3). 257–261. 10 indexed citations

20.

Janssen, William E., et al.. (1989). Non-specific cell binding characteristics of para-magnetic polystyrene microspheres used for antibody-mediated cell selection. Journal of Immunological Methods. 121(2). 289–294. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact